M32 Effect of Pirfenidone on All-Cause Mortality (Acm) and Forced Vital Capacity (Fvc) in Idiopathic Pulmonary Fibrosis (Ipf) Patients With Low FVC and/or Low Dlco: Analysis of Pooled Data From Ascend and Capacity
doi 10.1136/thoraxjnl-2017-210983.454
Full Text
Open PDFAbstract
Available in full text
Date
November 15, 2017
Authors
Publisher
BMJ Publishing Group Ltd and British Thoracic Society